EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Frequency and Hearing Loss Phenotypes of OPA1 Variants in a Cohort of 18,475 Patients with Hearing Impairment

Masayuki Kawakita, Hideaki Moteki iD, Shin-Ya Nishio iD, Yumiko Kobayashi iD, Mika Adachi, Takayuki Okano, Hiroshi Yamazaki, Jun Nakayama, Shinya Ohira, Takashi Ishino iD, Yutaka Takumi, Shin-Ichi Usami iD

Genes · 19.03.2026 · 17 (3) · 341

DOI: 10.3390/genes17030341 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, online erschienen am 19.03.2026. Verfasst von Masayuki Kawakita und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, Shinshu University School of Medicine, Matsumoto 390-8621, Japan. Hauptthemen laut MEDLINE: GTP Phosphohydrolases, Hearing Loss, Optic Atrophy, Autosomal Dominant, Hearing Loss, Central. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health, Labor and Welfare of Japan, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: The OPA1 gene encodes a dynamin-related GTPase essential for mitochondrial fusion. Variants in OPA1 are a major cause of autosomal dominant optic atrophy (DOA). A subset of DOA patients exhibits hearing loss, often manifesting as auditory neuropathy spectrum disorder (ANSD). In this study, we aimed to describe the frequency of OPA1-related hearing loss in a large cohort of patients with hearing loss and to explore the genotype–phenotype correlations and appropriate interventions.

Methods

A total of 18,475 Japanese patients with hearing loss were recruited. Targeted massively parallel sequencing of 158 deafness-related genes was performed, and individuals with OPA1 variants were identified. Clinical data, including age of onset, audiological findings, and systemic features, were retrospectively reviewed.

Results

Ten individuals from eight independent families carrying OPA1 variants were identified. Three variants were classified as pathogenic or likely pathogenic, while five were variants of uncertain significance. Hearing loss was typically post-lingual in onset and progressive, with predominantly mild-to-moderate severity. Missense variants tended to be associated with DOA-plus phenotypes and ANSD. Five patients obtained only limited benefit from hearing aids, whereas one patient who received a cochlear implant achieved good speech perception.

Conclusions

OPA1 is a rare causative gene for hearing loss and is frequently associated with the ANSD phenotype. Affected individuals exhibited phenotypic heterogeneity, which may reflect incomplete penetrance or the influence of mitochondrial DNA-related factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GTP PhosphohydrolasesHearing LossOptic Atrophy, Autosomal DominantHearing Loss, CentralHumansFemaleMalePhenotypeAdultMiddle AgedGenetic Association StudiesAdolescentChildYoung AdultAgedChild, PreschoolMutation, MissenseMutation

Stichwörter der Autor:innen

OPA1auditory neuropathy spectrum disordercochlear implantdominant optic atrophysyndromic hearing loss

Substanzen

OPA1 protein, humanGTP Phosphohydrolases

Autor:innen und Institutionen

  • Department of Otorhinolaryngology-Head and Neck Surgery, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.
  • Department of Hearing Implant Sciences, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.
  • Department of Otolaryngology, Aizawa Hospital, Matsumoto 390-8510, Japan.
  • Department of Clinical Genetics, Iwate Medical University, Morioka 020-8505, Japan.
  • Department of Otolaryngology-Head and Neck Surgery, Tohoku University Hospital, Sendai 980-8574, Japan.
  • Department of Otolaryngology-Head and Neck Surgery, Fujita Health University, Toyoake 470-1192, Japan.

ORCID-Profile: Hideaki Moteki, Shin-Ya Nishio, Yumiko Kobayashi, Takashi Ishino, Shin-Ichi Usami

Förderung

  • Ministry of Health, Labor and Welfare of Japan
  • Japan Agency for Medical Research and Development

Zitieren

APA

Kawakita, M., Moteki, H., Nishio, S. Y., Kobayashi, Y., Adachi, M., Okano, T., Yamazaki, H., Nakayama, J., Ohira, S., Ishino, T., Takumi, Y., & Usami, S. I. (2026). Frequency and Hearing Loss Phenotypes of OPA1 Variants in a Cohort of 18,475 Patients with Hearing Impairment. Genes, 17(3), 341. https://doi.org/10.3390/genes17030341

Vancouver

Kawakita M, Moteki H, Nishio SY, Kobayashi Y, Adachi M, Okano T, et al. Frequency and Hearing Loss Phenotypes of OPA1 Variants in a Cohort of 18,475 Patients with Hearing Impairment. Genes. 2026;17(3):341. doi:10.3390/genes17030341

BibTeX
@article{Kawakita2026,
  author = {Kawakita, Masayuki and Moteki, Hideaki and Nishio, Shin-Ya and Kobayashi, Yumiko and Adachi, Mika and Okano, Takayuki and Yamazaki, Hiroshi and Nakayama, Jun and Ohira, Shinya and Ishino, Takashi and Takumi, Yutaka and Usami, Shin-Ichi},
  title = {Frequency and Hearing Loss Phenotypes of OPA1 Variants in a Cohort of 18,475 Patients with Hearing Impairment},
  journal = {Genes},
  year = {2026},
  volume = {17},
  number = {3},
  pages = {341},
  doi = {10.3390/genes17030341}
}
Kostenlos starten →